• Ownership

Sven Ante Lundberg - Insider Trading & Ownership

Entity
Individual
Location
C/O Crispr Therapeutics Ag, 200 Sidney Street, Cambridge, MA
Summary
The estimated net worth of Sven Ante Lundberg is at least $5.88M dollars as of April 21, 2025. Sven Ante Lundberg is the President, CEO & PEO, Director of Merus N.V. and owns shares of Merus N.V. (MRUS) stock worth about $5.86M. Sven Ante Lundberg is the Director of Q32 Bio Inc. and owns shares of Q32 Bio Inc. (QTTB) stock worth about $18.3K.
All Insider Reports
All Insider Reports

Ownership of Sven Ante Lundberg

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MRUS Merus N.V. President, CEO & PEO, Director $5.86M Apr 17, 2025
QTTB Q32 Bio Inc. Director $18.3K Jan 15, 2025
VOR Vor Biopharma Inc. Director May 23, 2024

Insider Transactions Reported by Sven Ante Lundberg:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.